# Foqus Technologies Inc ## Posts - [Year in Review - Key Achievements for 2025](https://foqus.ca/year-in-review-key-achievements-for-2025/): As 2025 comes to a close, Foqus Technologies is proud to reflect on a year defined by achievement and growth. Across different functions, we have reached pivotal milestones that strengthen our foundation and position us for a transformative 2026. We are pleased to share these highlights and celebrate the progress that brings us closer to delivering next-generation MRI innovation to the world. Regulatory Success: FDA 510(k) Clearance One of Foqus’s most important achievements of 2025 was obtaining its first FDA 510(K) clearance for its AI-powered MRI acceleration software, DeepFoqus-Accelerate, enabling us to distribute the software to the U.S. market. This […] - [Foqus’s Co-Founder, Dr. Sadegh Raeisi, Recognized as One of Waterloo’s Top 10 Entrepreneurs to Watch](https://foqus.ca/foquss-co-founder-dr-sadegh-raeisi-recognized-as-one-of-waterloos-top-10-entrepreneurs-to-watch/): On November 17th, our CEO and co-founder, Dr. Sadegh Raeisi, was named one of the “10 Waterloo Outstanding Entrepreneurs to Watch” by the University of Waterloo during Global Entrepreneurship Week 2025. This recognition reflects our continued innovation, creativity, and dedication to delivering impactful solutions that are transforming medical imaging, making MRI faster, more accessible, and more impactful for healthcare systems and patients around the world. We are honored to be acknowledged by such a renowned institution and excited for the opportunities ahead as we prepare to bring our technology to clinicians, researchers, and health organizations across the North American market. […] - [Foqus Secures Funding Support from OBIO®](https://foqus.ca/foqus-secures-funding-support-from-obio/): Foqus Technologies is pleased to receive AI technology commercialization support from the Ontario Bioscience Innovation Organization (OBIO®) through its Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence. The LSCTC Centre supports the commercialization and adoption of innovative health technologies that drive intellectual property creation and strengthen Canada’s life sciences ecosystem. This funding will mainly support Foqus to explore and validate new concepts for the next generation of our machine learning algorithm — a key component of our Magnetic Resonance Imaging (MRI) software that powers advanced imaging performance With OBIO’s support, Foqus will continue to advance its technology and […] - [Foqus Secures NRC IRAP Funding to Advance Next-Generation Software](https://foqus.ca/foqus-secures-nrc-irap-funding-to-advance-next-generation-software/): Foqus Technologies is proud to announce that we are receiving advisory services and research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).  This support will accelerate the development and validation of the next-generation version of our software, DeepFoqus-Accelerate, enhancing performance and expanding its applications to serve a broader range of customers. With the support, Foqus continues to drive innovation and strengthen its competitive edge in the market. - [Foqus Technologies and Mohawk Medbuy Announce Joint Webinar on AI Advancements and Applications in Medical Imaging](https://foqus.ca/foqus-technologies-and-mohawk-medbuy-announce-joint-webinar-on-ai-advancements-and-applications-in-medical-imaginglive-webinar-hosted-by-foqus-technologies-and-medbuy/): Foqus Technologies is pleased to announce a joint live webinar with Mohawk Medbuy Corporation, scheduled for October 15, 2025. The webinar will highlight the transformative role of artificial intelligence (AI) in medical imaging and introduce DeepFoqus-Accelerate, Foqus’s AI-powered software, designed to improve medical imaging efficiency. About Mohawk MedbuyMohawk Medbuy is a national, not-for-profit organization dedicated to supporting hospitals and healthcare providers through strategic sourcing, procurement, and supply chain solutions. Their work supports healthcare systems in evaluating and adopting innovative, cost-saving solutions that drive efficiency and improve care delivery. https://www.mohawkmedbuy.ca We are honored to partner with Mohawk Medbuy for this event. This collaboration provides […] - [DeepFoqus-Accelerate Received Health Canada Approval](https://foqus.ca/deepfoqus-accelerate-received-health-canada-approved/): Foqus Technologies is proud to announce that DeepFoqus-Accelerate has received official approval from Health Canada, following its recent FDA 510(k) clearance. With both FDA 510(k) clearance and a Health Canada Medical Device Licence, Foqus is now poised to roll out its groundbreaking solutions to the North American market, delivering uncompromised images at accelerated speeds to shorten MRI scan times.  DeepFoqus-Accelerate addresses a critical need in healthcare systems, particularly in Canada, where the average MRI wait time is 3 to 4 months. By offering a cost-effective software solution, Foqus aims to improve access to timely and high-quality diagnostic imaging in both […] - [Foqus Technologies Featured by Velocity for Breakthroughs in MRI Innovation](https://foqus.ca/foqus-technologies-featured-by-velocity-for-breakthroughs-in-mri-innovation/): Foqus Technologies is honored to be recognized by Velocity for its recent milestones, including the successful completion of pilot programs and FDA 510(k) clearance for our DeepFoqus-Accelerate software. It highlights our continued commitment to improving timely access to magnetic resonance imaging (MRI) through faster and high-quality imaging. Read the full details: https://www.velocityincubator.com/momentum-2025#founders-watch Foqus is excited to continue working toward its goals and looks forward to bringing our innovative MRI solutions to market, making MRI more accessible by reducing scan times. - [Foqus Got Accepted into the Boston Canadian Technology Accelerator (CTA) Program 2025](https://foqus.ca/foqus-got-accepted-into-boston-canadian-technology-accelerator-cta-program-2025/): Foqus is proud to be selected for the Boston Canadian Technology Accelerator (CTA) program, a key initiative supporting high-potential companies in the Tech and Life Sciences sectors. The CTA program is designed to support companies that have high growth potential and are ready to grow in the international market by providing tailored mentoring and opportunities to connect with local ecosystems and key stakeholders. Boston, with its world-class MedTech and Life Sciences ecosystems, has been one of our strategic focuses in the U.S.  We look forward to gaining local business insights and refining market-entry strategies to better align with local needs, […] - [First Pilot Completed with Robarts Research Institute](https://foqus.ca/first-pilot-completed-with-robarts-research-institute-a-leadning-canadian-mri-facility/): Foqus Technologies recently completed a pilot project in collaboration with Robarts Research Institute to validate the performance of our software in real-world clinical settings. The pilot project was conducted at Robarts Research Institute to evaluate and assess the outcomes of using Foqus’s software with the existing 3T MRI systems. This collaboration has strengthened our partnership with Robarts Research Institute and enhanced our credibility. In addition, the outstanding results from the project validated the software’s performance and effectiveness, offering strong evidence to drive new collaborations and expand market adoption. - [DeepFoqus-Accelerate Received FDA 510(k) Clearance](https://foqus.ca/deefoqus-accelerate-received-fda-clearance/): Foqus Technologies, a pioneer that leverages both Quantum technologies and AI to enhance medical imaging, announces that its first AI-powered MRI reconstruction software, DeepFoqus-Accelerate, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Built on Foqus’s proprietary AI technology, DeepFoqus integrates with existing MRI systems and workflows to reduce scan times by 75% while maintaining image quality comparable to standard non-accelerated scans. This breakthrough will transform medical imaging and significantly empower healthcare providers to improve MRI efficiency, enhance the patient experience, and support better clinical outcomes. This FDA clearance marks a key milestone for Foqus to bring […] - [Foqus Received the ISO 13485:2016 Medical Device Single Audit Program (MDSAP) Quality Certificate](https://foqus.ca/medical-device-single-audit-program/): Foqus Technologies is excited to announce the successful attainment of the Medical Device Single Audit Program (MDSAP) certification, demonstrating full compliance with regulatory requirements in the United States and Canada. This achievement underscores our commitment to maintaining the highest standards of quality, safety, and regulatory compliance, ensuring that our first product meets the rigorous requirements set forth by regulatory bodies, including the FDA and Health Canada, and reinforcing trust in our technology as we scale to serve healthcare providers across North America. ## Pages - [Dashboard Page](https://foqus.ca/dashboard-page/) - [Technology](https://foqus.ca/technology/) - [Use Of Terms](https://foqus.ca/terms/): These Terms and Conditions (Terms) govern your use of our website. By accessing the website, you agree to be bound by these terms and all applicable laws and regulations. If you do not agree with any of these terms, please do not use this website. Use of Website You agree to use the website only for lawful purposes and in a way that does not infringe the rights of, restrict, or inhibit anyone else’s use. Intellectual property All content, trademarks, logos, images, and intellectual property on this website are owned by Foqus Technologies Inc., unless otherwise stated. You may not […] - [Privacy Policy](https://foqus.ca/privacy-policy/): Foqus is committed to maintaining the highest standard and priority for data privacy and protection. Foqus has established a privacy policy to implement proper measures and monitor possible security incidents. It is regularly reviewed and updated to ensure data protection procedures and measures are effective and comply with laws, regulations, and industry best practices. Information We Collect The policy applies to personal information provided by individuals who interact with us and the data automatically collected and stored by our servers. Standard Log and Device Data Foqus’ servers may automatically collect and store usage and device data when users navigate our […] - [Career](https://foqus.ca/career/) - [Blog](https://foqus.ca/blog/) - [Contact](https://foqus.ca/contact/) - [Home](https://foqus.ca/) [comment]: # (Generated by Hostinger Tools Plugin)